Allergan PLC issued a voluntary recall of a particular lot of physician sample packs of its contraceptive medicine Taytulla that were given out to physicians in the U.S. market.
The Irish drug giant had recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of Taytulla.
Allergan said the pack contained four nonhormonal placebo capsules instead of active capsules.
As a result of this packaging error, oral contraceptive capsules that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy, according to the company. The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order.
The company said it is notifying customers by recall letter and is arranging for return of the particular sample packs with the lot number 5620706.
